Sökning: onr:"swepub:oai:lup.lub.lu.se:a8416386-ad1a-470a-87dc-aa039af2033a" >
Interval breast can...
Interval breast cancer is associated with interferon immune response
-
- Ugalde-Morales, Emilio (författare)
- Karolinska Institutet,Karolinska Institute
-
- Grassmann, Felix (författare)
- Karolinska Institutet,Karolinska Institute,Health and Medical University
-
- Humphreys, Keith (författare)
- Karolinska Institutet,Karolinska Institute
-
visa fler...
-
- Li, Jingmei (författare)
- Karolinska Institute,National University of Singapore,A*Star, Genome Institute of Singapore (GIS)
-
- Eriksson, Mikael (författare)
- Karolinska Institutet,Karolinska Institute
-
- Tobin, Nicholas P. (författare)
- Karolinska Institutet,Karolinska Institute
-
- Lindström, Linda S. (författare)
- Karolinska Institutet,Karolinska Institute
-
- Vallon-Christersson, Johan (författare)
- Lund University,Lunds universitet,Create Health,Annan verksamhet, LTH,Lunds Tekniska Högskola,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Other operations, LTH,Faculty of Engineering, LTH,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments
-
- Borg, Åke (författare)
- Lund University,Lunds universitet,Create Health,Annan verksamhet, LTH,Lunds Tekniska Högskola,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Familjär bröstcancer,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Other operations, LTH,Faculty of Engineering, LTH,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Familial Breast Cancer,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments
-
- Hall, Per (författare)
- Karolinska Institutet,Karolinska Institute
-
- Czene, Kamila (författare)
- Karolinska Institutet,Karolinska Institute
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2022
- 2022
- Engelska 12 s.
-
Ingår i: European Journal of Cancer. - : Elsevier BV. - 0959-8049 .- 1879-0852. ; 162, s. 194-205
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
http://www.ejcancer....
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: The aggressive nature of breast cancers detected between planned mammographic screens, so-called interval cancers, remains elusive. Here, we aim to characterise underlying molecular features of interval cancer. Methods: From 672 patients with invasive breast cancer, we analysed gene expression differences between 90 ‘true’ interval cancer cases (i.e. women with low-dense breasts defined as per cent mammographic density <25%) and 310 screen-detected tumours while accounting for PAM50 subtypes and thus overall tumour aggressiveness. We computed an interval cancer gene expression profile (IC-Gx) in a total of 2270 breast tumours (regardless of interval cancer status) and tested for association with expression-based immune subtypes in breast cancer. In addition, we investigated the contribution of inherited and somatic genetic variants in distinct features of interval cancer. Results: We identified 8331 genes nominally associated with interval cancer (P-value < 0.05, fold-change > 1.5). Gene set enrichment analysis showed immune-related pathways as key processes altered in interval cancer. Our IC-Gx, based on 47 genes with the strongest associations (false discovery rate < 0.05), was found to be associated mainly with immune subtypes involving interferon response. We isolated an interaction network of interval cancer and interferon genes for which a significant load of somatic and germline variants in class I interferon genes was observed. Conclusion: We identified novel molecular features of interval breast cancer highlighting interferon pathways as a potential target for prevention or treatment.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Interferon immune response
- Interval breast cancer
- Mammographic density
- PAM50 subtypes
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Ugalde-Morales, ...
-
Grassmann, Felix
-
Humphreys, Keith
-
Li, Jingmei
-
Eriksson, Mikael
-
Tobin, Nicholas ...
-
visa fler...
-
Lindström, Linda ...
-
Vallon-Christers ...
-
Borg, Åke
-
Hall, Per
-
Czene, Kamila
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Lunds universitet
-
Karolinska Institutet